Biomedical researchers have got a permission to conduct an innovative clinical trial to determine if autologous cord blood stem cells could help treat autism. The trail was announced by Dr. Michael Chez, director of pediatric neurology at Sutter Neuroscience Institute in California. Dr. Chez got the idea to “treat” autism with cord blood stem cells when he observed the cells make a big difference for a little boy with cerebral palsy...
The first ever clinical trial for stem cell based voice box transplants will began soon in the United Kingdom. The trial is supported by Medical Research Council...
A groundbreaking clinical trial using autologous cord blood stem cells began in September 2012 in the US. The trial is dedicated to develop a new therapeutic procedure in the treatment of children suffering arterial ischemic stroke. The aim of the study is to determine if cord blood stem cells infusion will change physiologic response and anatomic findings in brain in children with perinatal arterial ischemic stroke...
Umbilical cord blood contains many types of stem cells capable of differentiation into many body tissues and cells. They could play a key role in the treatment of many diseases. Currently two teams of American biomedical scientist are evaluating new procedures involving cord blood for the treatment of autism and ischemic stroke in children. Growing importance of cord blood stem cells is also evident from European Parliament Report approved on 11 September 2012. Among others, the Report is calling for increase of cord blood stem cells inventory across European countries…
If you meet schoolboy Andrew he is cheerful, carefree and likes to run around with his friends. No one would guess that only a few years ago he was fighting for his life with a severe diagnosis. It was his own cord blood that helped him return to his family and friends.